Literature DB >> 6998808

Diabetic control in 102 insulin-treated out-patients.

G Tchobroutsky, D Charitanski, Y Blouquit, L Papoz, J Soria, J Rosa.   

Abstract

Haemoglobin AIc concentrations were measured in 102 insulin-treated diabetic outpatients. Only 19% had Hb AIc levels below three standard deviations above the normal mean value (5.23 +/- 0.05%). There were no correlations between Hb AIc levels, random C-peptide immunoreactivity or age. A significant correlation (r = 0.49; p < 0.001) was, however, observed between HbAIc and random plasma glucose levels. The mean random plasma glucose value was normal (89 +/- 18 mg/100 ml; 5 +/- 1 mmol/l) in the patients on insulin three times a day who had received short acting insulin 160 +/- 6 min before the sampling. --A significant inverse correlation was found (r = -0.26; p < 0.01) between the number of daily insulin injections and the HbAIc concentration. --These results suggest that the use of multiple daily insulin injections improves diabetic control. It should however be emphasised that the patients receiving multiple insulin injections were younger than those on the single injection regime and had lower plasma insulin antibody titres, different social and psychological status and a shorter duration of the disease.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6998808     DOI: 10.1007/bf00261699

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  20 in total

1.  Immunologic aspects of insulin.

Authors:  R S YALOW; S A BERSON
Journal:  Am J Med       Date:  1961-12       Impact factor: 4.965

2.  Hemoglobin AIc as an indicator of the degree of glucose intolerance in diabetes.

Authors:  R J Koenig; C M Peterson; C Kilo; A Cerami; J R Williamson
Journal:  Diabetes       Date:  1976-03       Impact factor: 9.461

Review 3.  Haemoglobin A1 and diabetes mellitus.

Authors:  G Gonen; A H Rubenstein
Journal:  Diabetologia       Date:  1978-07       Impact factor: 10.122

4.  Separation of antibody-bound and unbound peptide hormones labelled with iodine-131 by talcum powder and precipitated silica.

Authors:  G Rosselin; R Assan; R S Yalow; S A Berson
Journal:  Nature       Date:  1966-10-22       Impact factor: 49.962

5.  Lack of post prandial exercise-induced growth hormone secretion in normoglycemic insulin-treated diabetic men.

Authors:  G Tchobroutsky; M E Lenormand; G Michel; R Assan
Journal:  Horm Metab Res       Date:  1974-05       Impact factor: 2.936

6.  Serial postprandial blood glucose levels in 309 subjects with and without diabetes.

Authors:  A Kopf; G Tchobroutsky; E Eschwege
Journal:  Diabetes       Date:  1973-11       Impact factor: 9.461

7.  Human C-peptide immunoreactivity (CPR) in blood and urine - evaluation of a radioimmunoassay method and its clinical applications.

Authors:  T Kuzuya; T Saito; S Yoshida; A Matsuda
Journal:  Diabetologia       Date:  1976-10       Impact factor: 10.122

8.  Insulin therapy in relation to circulating C-peptide levels.

Authors:  W Beischer; W Kerner; S Raptis; L Keller; B Beischer; E F Pfeiffer
Journal:  Diabetes       Date:  1978       Impact factor: 9.461

9.  Haemoglobin A1: An indicator of the metabolic control of diabetic patients.

Authors:  B Gonen; A Rubenstein; H Rochman; S P Tanega; D L Horwitz
Journal:  Lancet       Date:  1977-10-08       Impact factor: 79.321

10.  Glycosylated hemoglobins and long-term blood glucose control in diabetes mellitus.

Authors:  K H Gabbay; K Hasty; J L Breslow; R C Ellison; H F Bunn; P M Gallop
Journal:  J Clin Endocrinol Metab       Date:  1977-05       Impact factor: 5.958

View more
  8 in total

1.  Meta-analysis in medicine.

Authors:  A G Shannon
Journal:  J R Soc Med       Date:  1986-11       Impact factor: 5.344

2.  Hypoglycaemic reactions in 172 Type 1 (insulin-dependent) diabetic patients.

Authors:  C Goldgewicht; G Slama; L Papoz; G Tchobroutsky
Journal:  Diabetologia       Date:  1983-02       Impact factor: 10.122

3.  Diabetes care: whose responsibility?

Authors:  P Home; S Walford
Journal:  Br Med J (Clin Res Ed)       Date:  1984-09-22

4.  Diabetic control on once- and twice-daily insulin injections.

Authors:  B J Boucher; C Walton; S G Welch; D Barnett; J S Yudkin; J P Monson
Journal:  Diabetologia       Date:  1980-11       Impact factor: 10.122

Review 5.  Blood glucose levels in diabetic and non-diabetic subjects.

Authors:  G Tchobroutsky
Journal:  Diabetologia       Date:  1991-02       Impact factor: 10.122

6.  Metabolic control of diabetes in general practice clinics: comparison with a hospital clinic.

Authors:  B M Singh; M R Holland; P A Thorn
Journal:  Br Med J (Clin Res Ed)       Date:  1984-09-22

7.  HLA antigens and risk factors for nephropathy in type 1 (insulin-dependent) diabetes mellitus.

Authors:  C Walton; P A Dyer; J A Davidson; R Harris; N P Mallick; S Oleesky
Journal:  Diabetologia       Date:  1984-07       Impact factor: 10.122

8.  Remission phase, endogenous insulin secretion and metabolic control in diabetic children.

Authors:  M Knip; R Puukka; M L Käär; H K Akerblom
Journal:  Acta Diabetol Lat       Date:  1982 Jul-Sep
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.